Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Nankivell · SciRah

Researcher profile · Semantic Scholar

M. Nankivell

Share profile

M. Nankivell — researcher profile on SciRah

h-index: 31
Works: 133
Citations: 8,680

Most-cited papers

Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial
P. Mulvenna, M. Nankivell, R. Barton, C. Faivre-Finn +15 more
2016The Lancet2,292 citations Open access
Semantic Scholar
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.
S. Kehoe, J. Hook, M. Nankivell, G. Jayson +13 more
2015The Lancet1,286 citations
Semantic Scholar
Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial
E. Smyth, A. Wotherspoon, C. Peckitt, D. Gonzalez +12 more
2017JAMA Oncology496 citations Open access
Semantic Scholar
Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer.
F. Pietrantonio, R. Miceli, A. Raimondi, Y. Kim +20 more
2019Journal of Clinical Oncology413 citations Open access
Semantic Scholar
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis
B. Lacas, J. Bourhis, J. Overgaard, Q. Zhang +26 more
2017The Lancet Oncology299 citations Open access
Semantic Scholar
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.
I. Vergote, C. Coens, M. Nankivell, G. Kristensen +134 more
2018The Lancet Oncology270 citations Open access
Semantic Scholar
Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial
E. Smyth, M. Fassan, D. Cunningham, W. Allum +12 more
2016Journal of Clinical Oncology269 citations Open access
Semantic Scholar
Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial
N. Navani, M. Nankivell, D. Lawrence, S. Lock +7 more
2015The Lancet Respiratory Medicine242 citations Open access
Semantic Scholar
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial
D. Alderson, D. Cunningham, M. Nankivell, J. Blazeby +13 more
2017The Lancet Oncology210 citations Open access
Semantic Scholar
Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial
D. Stark, M. Nankivell, E. Pujade-Lauraine, G. Kristensen +15 more
2013The Lancet Oncology150 citations Open access
Semantic Scholar
Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort study
H. Muti, Lara R. Heij, G. Keller, Meike Kohlruss +31 more
2021The Lancet Digital Health104 citations Open access
Semantic Scholar
Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: Results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072).
D. Alderson, R. E. Langley, M. Nankivell, J. Blazeby +13 more
201590 citations
Semantic Scholar
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis.
C. Petit, B. Lacas, J. Pignon, Q. Le +165 more
2021The Lancet Oncology86 citations Open access
Semantic Scholar
Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study
L. Hewitt, I. Inam, Y. Saito, T. Yoshikawa +11 more
2018European Journal of Cancer56 citations Open access
Semantic Scholar
Quality‐of‐life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone‐releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer
D. Gilbert, T. Duong, H. Kynaston, A. Alhasso +14 more
2017BJU International49 citations Open access
Semantic Scholar
A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer.
C. Lee, R. Simes, Chris Brown, V. Gebski +20 more
2013Annals of Oncology42 citations Open access
Semantic Scholar
Impact of sex and age on chemotherapy efficacy, toxicity and survival in localised oesophagogastric cancer: A pooled analysis of 3265 individual patient data from four large randomised trials (OE02, OE05, MAGIC and ST03).
A. Athauda, M. Nankivell, R. Langley, D. Alderson +5 more
2020European Journal of Cancer39 citations Open access
Semantic Scholar
Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy – results from the MRC OE02 oesophageal cancer trial
Nasser Davarzani, G. Hutchins, N. West, L. Hewitt +7 more
2018Histopathology38 citations Open access
Semantic Scholar
A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial
E. Smyth, G. Nyamundanda, D. Cunningham, E. Fontana +19 more
2018Annals of Oncology38 citations Open access
Semantic Scholar
Primary Surgery or Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: The Debate Continues….
A. Leary, R. Cowan, D. Chi, S. Kehoe +1 more
2016American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting35 citations
Semantic Scholar
Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma
M. Faron, M. Cheugoua-Zanetsie, J. Tierney, Pierre Thirion +30 more
2023Journal of Clinical Oncology34 citations Open access
Semantic Scholar
Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme
R. Langley, D. Gilbert, T. Duong, N. Clarke +27 more
2021The Lancet32 citations Open access
Semantic Scholar
Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for PD-L1 Testing In Non-Small Cell Lung Cancer.
F. Perrotta, M. Nankivell, B. Adizie, U. Maqsood +13 more
2020Chest30 citations Open access
Semantic Scholar
Whole brain radiotherapy for brain metastases from non-small lung cancer: Quality of life (QoL) and overall survival (OS) results from the UK Medical Research Council QUARTZ randomised clinical trial (ISRCTN 3826061).
P. Mulvenna, M. Nankivell, R. Barton, C. Faivre-Finn +15 more
201528 citations Open access
Semantic Scholar
Primary Surgery or Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: The Debate Continues….
R. Cowan, D. Chi, S. Kehoe, M. Nankivell +1 more
2016American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting21 citations
Semantic Scholar
Cost Effectiveness of Modified Fractionation Radiotherapy versus Conventional Radiotherapy for Unresected Non–Small-Cell Lung Cancer Patients
B. Ramaekers, M. Joore, B. Lueza, J. Bonastre +34 more
2013Journal of Thoracic Oncology21 citations Open access
Semantic Scholar
MSI-GC-01: Individual patient data (IPD) meta-analysis of microsatellite instability (MSI) and gastric cancer (GC) from four randomized clinical trials (RCTs).
F. Pietrantonio, A. Raimondi, Yoon Young Choi, W. Kang +16 more
2019Journal of Clinical Oncology20 citations
Semantic Scholar
Pathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trials
A. Athauda, M. Nankivell, R. Langer, S. Pritchard +6 more
2023British Journal of Cancer19 citations Open access
Semantic Scholar
REFINE (REduced Frequency ImmuNE checkpoint inhibition in cancers): A multi-arm phase II basket trial testing reduced intensity immunotherapy across different cancers
S. Merrick, M. Nankivell, Matteo Quartagno, C. Clarke +16 more
2022Contemporary Clinical Trials18 citations Open access
Semantic Scholar
Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screening
Sheng-Qing Gu, S. Lheureux, A. Sayad, P. Cybulska +13 more
2021Proceedings of the National Academy of Sciences of the United States of America17 citations Open access
Semantic Scholar
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial
B. Grosser, J. Emmerson, N. Reitsam, D. Cunningham +6 more
2023British Journal of Cancer16 citations Open access
Semantic Scholar
Retrospective response analysis of BAP1 expression to predict the clinical activity of systemic cytotoxic chemotherapy in mesothelioma.
Neelam Kumar, D. Alrifai, K. Kolluri, E. Sage +7 more
2019Lung Cancer16 citations Open access
Semantic Scholar
Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trial
Matthew D. Hale, M. Nankivell, G. Hutchins, S. Stenning +10 more
2016OncoTarget16 citations Open access
Semantic Scholar
Neoadjuvant CTLA-4/PD-(L)1 Blockade Versus Surgery +/- Chemotherapy in Deficient Mismatch Repair/Microsatellite Instability-High Resectable Gastroesophageal Adenocarcinoma: Individual Patient Data Pooled Analysis.
A. Raimondi, G. Tine', A. Ballhausen, S. Lonardi +23 more
2025Journal of Clinical Oncology14 citations Open access
Semantic Scholar
Individual patient data meta-analysis of neoadjuvant chemotherapy followed by surgery versus upfront surgery for carcinoma of the oesophagus or the gastro-oesophageal junction.
M. Faron, Armel Maurice Cheugoua-Zanetsie, P. Thirion, M. Nankivell +19 more
2021European Journal of Cancer13 citations Open access
Semantic Scholar
Prognostic Significance of Negative Lymph Node Long Axis in Esophageal Cancer
M. Kloft, J. Ruisch, G. Raghuram, J. Emmerson +5 more
2021Annals of Surgery13 citations Open access
Semantic Scholar
Interim results in clinical trials: do we need to keep all interim randomised clinical trial results confidential?
R. Stephens, R. Langley, P. Mulvenna, M. Nankivell +2 more
2014Lung Cancer13 citations Open access
Semantic Scholar
Pharmacogenetic analysis of the UKMRC (Medical Research Council) MAGIC trial: association of polymorphisms with toxicity and survival in patients treated with perioperative epirubicin, cisplatin and 5-fluorouracil (ECF) chemotherapy
E. Smyth, Shenli Zhang, D. Cunningham, A. Wotherspoon +11 more
2017Clinical Cancer Research12 citations Open access
Semantic Scholar
LBA-03Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072)
D. Cunningham, R. Langley, M. Nankivell, J. Blazeby +13 more
201511 citations Open access
Semantic Scholar
Preoperative Chemoradiotherapy vs Chemotherapy for Adenocarcinoma of the Esophagogastric Junction
Ulrich Ronellenfitsch, Juliane Friedrichs, E. Barbier, G. Bass +27 more
2024JAMA Network Open10 citations Open access
Semantic Scholar
A comparison of different population-level summary measures for randomised trials with time-to-event outcomes, with a focus on non-inferiority trials
Matteo Quartagno, T. Morris, D. Gilbert, R. Langley +3 more
2023Clinical Trials9 citations Open access
Semantic Scholar
Primary chemotherapy versus primary surgery for ovarian cancer - Authors' reply.
S. Kehoe, M. Nankivell
2015The Lancet9 citations
Semantic Scholar
Technical reproducibility of single-nucleotide and size-based DNA biomarker assessment using DNA extracted from formalin-fixed, paraffin-embedded tissues.
Shenli Zhang, I. Tan, N. S. Sapari, H. Grabsch +14 more
2015Journal of Molecular Diagnostics8 citations Open access
Semantic Scholar
Toxicity, surgical complications, and short-term mortality in a randomized trial of neoadjuvant cisplatin/5FU versus epirubicin/cisplatin and capecitabine prior to resection of lower esophageal/gastroesophageal junction (GOJ) adenocarcinoma (MRC OEO5, ISRCTN01852072, CRUK 02/010).
D. Cunningham, D. Alderson, M. Nankivell, S. Stenning +8 more
20148 citations
Semantic Scholar
Neoadjuvant chemotherapy improves survival in patients with oesophageal mucinous adenocarcinoma: Post-hoc analysis of the UK MRC OE02 and OE05 trials.
Drolaiz H. W. Liu, Nina Šefčovičová, J. Emmerson, L. Spaans +8 more
2022European Journal of Cancer6 citations Open access
Semantic Scholar
Prognostic and predictive impact of sex in locally advanced microsatellite instability high gastric or gastroesophageal junction cancer: An individual patient data pooled analysis of randomized clinical trials.
A. Raimondi, Y. Kim, Won-Ki Kang, R. E. Langley +19 more
2024European Journal of Cancer5 citations Open access
Semantic Scholar
Healthcare systems data in the context of clinical trials − A comparison of cardiovascular data from a clinical trial dataset with routinely collected data
A. Macnair, M. Nankivell, M. Murray, Stuart D. Rosen +14 more
2023Contemporary Clinical Trials5 citations Open access
Semantic Scholar
DNA epigenetic signature predictive of benefit from neoadjuvant chemotherapy in oesophageal adenocarcinoma: results from the MRC OE02 trial.
R. Sundar, A. Ng, Hermioni Zouridis, Nisha T. Padmanabhan +17 more
2019European Journal of Cancer5 citations Open access
Semantic Scholar
Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy.
N. Cabrit, M. Cheugoua-Zanetsie, J. Tierney, Pierre Thirion +29 more
2025European Journal of Cancer4 citations Open access
Semantic Scholar
Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma
Arnaldo N. S. Silva, Y. Saito, T. Yoshikawa, T. Oshima +13 more
2022British Journal of Surgery4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Langley×25
Invite
R. Langley — researcher profile on SciRah
D. Cunningham×17
Invite
D. Cunningham — researcher profile on SciRah
H. Grabsch×17
Invite
H. Grabsch — researcher profile on SciRah
W. Allum×14
Invite
W. Allum — researcher profile on SciRah

×8

Invite

E. Smyth — researcher profile on SciRah

Invite

A. Okines — researcher profile on SciRah

Invite

S. Stenning — researcher profile on SciRah

Invite

M. Parmar — researcher profile on SciRah

Invite

J. Pignon — researcher profile on SciRah

A. Wotherspoon×7

Invite

A. Wotherspoon — researcher profile on SciRah

Invite

S. Kehoe — researcher profile on SciRah

Invite

N. Valeri — researcher profile on SciRah